These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

300 related items for PubMed ID: 30510007

  • 1. Polysaccharide structure dictates mechanism of adaptive immune response to glycoconjugate vaccines.
    Sun X, Stefanetti G, Berti F, Kasper DL.
    Proc Natl Acad Sci U S A; 2019 Jan 02; 116(1):193-198. PubMed ID: 30510007
    [Abstract] [Full Text] [Related]

  • 2. Carrier priming effect of CRM197 is related to an enhanced B and T cell activation in meningococcal serogroup A conjugate vaccination. Immunological comparison between CRM197 and diphtheria toxoid.
    Pecetta S, Tontini M, Faenzi E, Cioncada R, Proietti D, Seubert A, Nuti S, Berti F, Romano MR.
    Vaccine; 2016 Apr 29; 34(20):2334-41. PubMed ID: 27015733
    [Abstract] [Full Text] [Related]

  • 3. Synthesis and immunological study of α-2,9-oligosialic acid conjugates as anti-group C meningitis vaccines.
    Liao G, Zhou Z, Guo Z.
    Chem Commun (Camb); 2015 Jun 14; 51(47):9647-50. PubMed ID: 25973942
    [Abstract] [Full Text] [Related]

  • 4. Preclinical studies on new proteins as carrier for glycoconjugate vaccines.
    Tontini M, Romano MR, Proietti D, Balducci E, Micoli F, Balocchi C, Santini L, Masignani V, Berti F, Costantino P.
    Vaccine; 2016 Jul 29; 34(35):4235-4242. PubMed ID: 27317455
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Carrier-mediated enhancement of cognate T cell help: the basis for enhanced immunogenicity of meningococcal outer membrane protein polysaccharide conjugate vaccine.
    Pérez-Melgosa M, Ochs HD, Linsley PS, Laman JD, van Meurs M, Flavell RA, Ernst RK, Miller SI, Wilson CB.
    Eur J Immunol; 2001 Aug 29; 31(8):2373-81. PubMed ID: 11500820
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Carrier priming with CRM 197 or diphtheria toxoid has a different impact on the immunogenicity of the respective glycoconjugates: biophysical and immunochemical interpretation.
    Pecetta S, Lo Surdo P, Tontini M, Proietti D, Zambonelli C, Bottomley MJ, Biagini M, Berti F, Costantino P, Romano MR, Study Group.
    Vaccine; 2015 Jan 03; 33(2):314-20. PubMed ID: 25448110
    [Abstract] [Full Text] [Related]

  • 11. A preliminary study on the application of PspA as a carrier for group A meningococcal polysaccharide.
    Wang L, Tan Y, Wei C, Zhang H, Luo P, Zhang S, Ma X.
    PLoS One; 2019 Jan 03; 14(7):e0218427. PubMed ID: 31291272
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Chemoenzymatic synthesis of immunogenic meningococcal group C polysialic acid-tetanus Hc fragment glycoconjugates.
    McCarthy PC, Saksena R, Peterson DC, Lee CH, An Y, Cipollo JF, Vann WF.
    Glycoconj J; 2013 Dec 03; 30(9):857-70. PubMed ID: 23949787
    [Abstract] [Full Text] [Related]

  • 14. Carbohydrates and T cells: a sweet twosome.
    Avci FY, Li X, Tsuji M, Kasper DL.
    Semin Immunol; 2013 Apr 03; 25(2):146-51. PubMed ID: 23757291
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Sequential Linkage of Carbohydrate Antigens to Mimic Capsular Polysaccharides: Toward Semisynthetic Glycoconjugate Vaccine Candidates against Streptococcus pneumoniae Serotype 14.
    Seco BMS, Xu FF, Grafmüller A, Kottari N, Pereira CL, Seeberger PH.
    ACS Chem Biol; 2020 Sep 18; 15(9):2395-2405. PubMed ID: 32835479
    [Abstract] [Full Text] [Related]

  • 17. Moderate PEGylation of the carrier protein improves the polysaccharide-specific immunogenicity of meningococcal group A polysaccharide conjugate vaccine.
    Zhang T, Yu W, Wang Y, Hu T.
    Vaccine; 2015 Jun 22; 33(28):3208-14. PubMed ID: 25964170
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Evaluation of impact of temperature and pH alterations on the size and antigenicity of meningococcal serogroup A and X polysaccharides and conjugates.
    Sharma N, Hanif S, Rana R, Upadhyay D, Chhikara MK.
    Vaccine; 2019 Feb 08; 37(7):965-972. PubMed ID: 30651197
    [Abstract] [Full Text] [Related]

  • 20. Bordetella pertussis fimbriae are effective carrier proteins in Neisseria meningitidis serogroup C conjugate vaccines.
    Reddin KM, Crowley-Luke A, Clark SO, Vincent PJ, Gorringe AR, Hudson MJ, Robinson A.
    FEMS Immunol Med Microbiol; 2001 Aug 08; 31(2):153-62. PubMed ID: 11549423
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.